{"title":"刺蒺藜显著改善类风湿关节炎患者Th17/Treg失衡:伊朗一项随机双盲、安慰剂对照临床试验","authors":"Sajad Dehnavi , Zhaleh Shariati-Sarabi , Hassan Rakhshandeh , Mohsen Ghoryani , Jalil Tavakol Afshari , Leila Mobasheri , Mojgan Mohammadi","doi":"10.1016/j.jff.2025.106926","DOIUrl":null,"url":null,"abstract":"<div><div><strong><em>Aim:</em></strong> This study investigated the therapeutic effect of <em>C. spinosa</em> on clinical and laboratory indices, and the T lymphocyte populations in refractory female RA patients as a randomized, double-blind placebo-controlled, clinical trial (IRCT20151028024760N5). <strong><em>Materials and Methods:</em></strong> Thirty informed women with refractory RA were randomly divided into three groups including <em>C. spinosa</em>, placebo (, and control. The therapeutic regimen was continued for three consecutive months. Before and after the intervention, patients were evaluated for VAS pain score, DAS28, DAS28-ESR, ESR, CRP, RF, and anti-CCP antibody parameters. Blood samples were also collected to evaluate the percentage of CD4+ T, CD8+ T, Treg, and Th17 cells by flow cytometry. <strong><em>Results and conclusion:</em></strong> <em>C. spinosa</em> treatment significantly reduced VAS pain score (<em>p</em> = 0.0001), DAS28 (<em>p</em> = 0.007), DAS28-ESR (<em>p</em> = 0.001), ESR (<em>p</em> = 0.003), and CRP (<em>p</em> = 0.026) levels. In addition, <em>C. spinosa</em> treatment significantly increased the Treg population (p = 0.02) and Treg/Th17 ratio (<em>p</em> = 0.0015), while decreased Th17 percentage (<em>p</em> = 0.04).</div></div>","PeriodicalId":360,"journal":{"name":"Journal of Functional Foods","volume":"130 ","pages":"Article 106926"},"PeriodicalIF":3.8000,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Capparis spinosa significantly improves Th17/Treg imbalance in patients with rheumatoid arthritis: A randomized double blind, placebo-controlled clinical trial in Iran\",\"authors\":\"Sajad Dehnavi , Zhaleh Shariati-Sarabi , Hassan Rakhshandeh , Mohsen Ghoryani , Jalil Tavakol Afshari , Leila Mobasheri , Mojgan Mohammadi\",\"doi\":\"10.1016/j.jff.2025.106926\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><strong><em>Aim:</em></strong> This study investigated the therapeutic effect of <em>C. spinosa</em> on clinical and laboratory indices, and the T lymphocyte populations in refractory female RA patients as a randomized, double-blind placebo-controlled, clinical trial (IRCT20151028024760N5). <strong><em>Materials and Methods:</em></strong> Thirty informed women with refractory RA were randomly divided into three groups including <em>C. spinosa</em>, placebo (, and control. The therapeutic regimen was continued for three consecutive months. Before and after the intervention, patients were evaluated for VAS pain score, DAS28, DAS28-ESR, ESR, CRP, RF, and anti-CCP antibody parameters. Blood samples were also collected to evaluate the percentage of CD4+ T, CD8+ T, Treg, and Th17 cells by flow cytometry. <strong><em>Results and conclusion:</em></strong> <em>C. spinosa</em> treatment significantly reduced VAS pain score (<em>p</em> = 0.0001), DAS28 (<em>p</em> = 0.007), DAS28-ESR (<em>p</em> = 0.001), ESR (<em>p</em> = 0.003), and CRP (<em>p</em> = 0.026) levels. In addition, <em>C. spinosa</em> treatment significantly increased the Treg population (p = 0.02) and Treg/Th17 ratio (<em>p</em> = 0.0015), while decreased Th17 percentage (<em>p</em> = 0.04).</div></div>\",\"PeriodicalId\":360,\"journal\":{\"name\":\"Journal of Functional Foods\",\"volume\":\"130 \",\"pages\":\"Article 106926\"},\"PeriodicalIF\":3.8000,\"publicationDate\":\"2025-06-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Functional Foods\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1756464625002683\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"FOOD SCIENCE & TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Functional Foods","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1756464625002683","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"FOOD SCIENCE & TECHNOLOGY","Score":null,"Total":0}
Capparis spinosa significantly improves Th17/Treg imbalance in patients with rheumatoid arthritis: A randomized double blind, placebo-controlled clinical trial in Iran
Aim: This study investigated the therapeutic effect of C. spinosa on clinical and laboratory indices, and the T lymphocyte populations in refractory female RA patients as a randomized, double-blind placebo-controlled, clinical trial (IRCT20151028024760N5). Materials and Methods: Thirty informed women with refractory RA were randomly divided into three groups including C. spinosa, placebo (, and control. The therapeutic regimen was continued for three consecutive months. Before and after the intervention, patients were evaluated for VAS pain score, DAS28, DAS28-ESR, ESR, CRP, RF, and anti-CCP antibody parameters. Blood samples were also collected to evaluate the percentage of CD4+ T, CD8+ T, Treg, and Th17 cells by flow cytometry. Results and conclusion:C. spinosa treatment significantly reduced VAS pain score (p = 0.0001), DAS28 (p = 0.007), DAS28-ESR (p = 0.001), ESR (p = 0.003), and CRP (p = 0.026) levels. In addition, C. spinosa treatment significantly increased the Treg population (p = 0.02) and Treg/Th17 ratio (p = 0.0015), while decreased Th17 percentage (p = 0.04).
期刊介绍:
Journal of Functional Foods continues with the same aims and scope, editorial team, submission system and rigorous peer review. We give authors the possibility to publish their top-quality papers in a well-established leading journal in the food and nutrition fields. The Journal will keep its rigorous criteria to screen high impact research addressing relevant scientific topics and performed by sound methodologies.
The Journal of Functional Foods aims to bring together the results of fundamental and applied research into healthy foods and biologically active food ingredients.
The Journal is centered in the specific area at the boundaries among food technology, nutrition and health welcoming papers having a good interdisciplinary approach. The Journal will cover the fields of plant bioactives; dietary fibre, probiotics; functional lipids; bioactive peptides; vitamins, minerals and botanicals and other dietary supplements. Nutritional and technological aspects related to the development of functional foods and beverages are of core interest to the journal. Experimental works dealing with food digestion, bioavailability of food bioactives and on the mechanisms by which foods and their components are able to modulate physiological parameters connected with disease prevention are of particular interest as well as those dealing with personalized nutrition and nutritional needs in pathological subjects.